What “Controlled Diabetes” Doesn’t Measure: The Three Things Your A1C Number Misses.

If your A1C is “in range” but you still feel exhausted, your feet still tingle, or your legs still cramp at night — there is a reasonable scientific explanation, and it does not involve dismissing what you are feeling. The A1C number measures one thing well. There are at least three things it does not measure at all. The damage that diabetes does to nerves, blood vessels, and cells often happens in the gaps that A1C cannot see.

This article walks through what A1C actually measures, the categories of glucose-related damage it misses, and what the research says about why two people with the same A1C can have very different bodies. We are not telling anyone to stop trusting their doctor or their lab results. The goal is to give a clearer picture of what a more complete answer would look like — so the next conversation with a clinician can be a more informed one.

What A1C actually measures

A1C — sometimes written HbA1c — measures the percentage of hemoglobin in your red blood cells that has glucose stuck to it. The more glucose floating in your blood over time, the more of your hemoglobin gets glycated. Because red blood cells live around 90 to 120 days, the test reflects an average of glucose exposure over the previous two to three months.

That is genuinely useful information. Higher average glucose damages tissues. Lower average glucose damages tissues less. Bringing A1C down has been a central goal of diabetes care for forty years for good reason.

But “average” is doing a lot of work in that sentence.

Problem 1: averages hide spikes

A 2019 international consensus statement on continuous glucose monitoring put it plainly. While A1C reflects average glucose over the last two to three months, it does not capture the magnitude or frequency of glucose variation, and the same A1C value can hide very different glucose patterns.¹

Imagine two people with type 2 diabetes. Both have an A1C of 7.0%. Their estimated average glucose over three months is roughly the same. But:

Person A’s glucose stays between 100 and 160 mg/dL most of the day. Steady, modest, predictable.

Person B’s glucose falls to 65 some afternoons and spikes to 280 after dinner. Same average. Different body.

Their lab reports look identical. Their nerves and blood vessels do not.

Research has found that HbA1c variability — measured as how much the value swings from one test to the next over months and years — is associated with diabetic complications independently of the average HbA1c. A 2024 analysis published in the Journal of Diabetes Science and Technology found that higher A1C variability was independently associated with greater risk of microvascular complications in type 1 diabetes, even after adjusting for the average A1C and other risk factors.² Similar patterns have been reported in type 2 diabetes for both microvascular and cardiovascular outcomes, though the literature is mixed and a minority of studies have not found the association.

The implication: how steady your glucose is may matter as much as where the average sits.

A “controlled” A1C and a steady body are not the same question.

Problem 2: post-meal spikes do damage that average glucose can’t see

After a meal, blood glucose rises. In someone without diabetes, it rises modestly and falls back to baseline within two hours. In type 2 diabetes, the rise is bigger, lasts longer, and reaches higher peaks.

A 2009 review in Cardiovascular Diabetology described the case that postprandial hyperglycemia — the post-meal spike — independently predicts cardiovascular events, in some studies more strongly than fasting glucose. The proposed mechanisms include damage to the lining of blood vessels (called endothelial dysfunction), oxidative stress, and inflammation that cascade from each spike.³

A 2020 review in Frontiers in Cardiovascular Medicine added that postprandial glucose levels can be more predictive of cardiovascular disease than HbA1c — even in people without a diabetes diagnosis. The same review noted that for fasting glucose there appears to be a threshold effect, but for post-meal glucose, the relationship with cardiovascular risk appears to be a continuum.⁴

A1C is influenced by these spikes, but it averages them out. Two patients can have identical A1Cs — with one experiencing modest, brief post-meal spikes and the other experiencing large, prolonged ones. The damage curve is different.

There is one detail worth knowing. The post-meal contribution to total glucose damage is greatest in patients whose A1C is closest to target. A 2003 paper by Monnier and colleagues in Diabetes Care found that postprandial glucose accounts for roughly 70% of the day’s total hyperglycemia in patients with A1C below 7.3%, dropping to about 30% in patients with A1C above 10.2%.⁵

In other words: the better your A1C looks, the more of the remaining glucose damage is happening after meals — exactly where A1C cannot see it well.

Problem 3: A1C measures nothing about what’s happening inside cells

A1C is a blood test. It tells you something about the glucose in the bloodstream and how it has interacted with your red blood cells. It tells you nothing about what is happening inside the cells of your nerves, muscles, and organs.

This matters because the symptoms that bring people to ask “why don’t I feel right?” — fatigue, cramps, tingling, sleep disruption — often originate at the cellular level. The state of glucose in the blood and the state of nutrients inside cells are different questions, with different answers, measured by different tests.

Magnesium is one example. Less than 1% of the body’s magnesium is in the bloodstream — the rest sits inside cells and bone.⁶ A standard serum magnesium test reflects only that small extracellular fraction. So a normal result does not necessarily mean total body magnesium is adequate.

A 2024 meta-analysis pooled 19 studies and reported a prevalence of low serum magnesium around 32% in people with type 2 diabetes.⁷ Because the body works hard to keep blood magnesium normal by pulling it from inside cells, intracellular depletion can develop and progress while standard blood work continues to read fine. This pattern is discussed in the literature for several common nutrients, including B12 in long-term metformin users.

So when a person has a “normal” A1C and a “normal” magnesium and still feels something is wrong — that is not a contradiction. The standard tests are answering a narrow question. The body is asking a wider one.

A fourth issue: A1C itself can be wrong

This one is less about what A1C misses and more about when A1C lies.

The A1C test depends on the lifespan of red blood cells. Anything that changes that lifespan changes the result. A 2014 review in the Journal of General Internal Medicine identified multiple conditions that distort A1C measurement:⁸

Iron deficiency anemia, vitamin B12 deficiency, and folate deficiency tend to falsely raise A1C.

Hemolytic anemia, recent blood loss, and many hemoglobin variants tend to falsely lower it.

Chronic kidney disease, late-stage liver disease, pregnancy, and certain inherited hemoglobin variants can shift the result either direction.

Lead exposure, chronic alcoholism, and opioid use are recognized confounders.

The National Glycohemoglobin Standardization Program — the body that hospitals reference for A1C interpretation — maintains a similar list.⁹

This is not exotic territory. Iron deficiency is common, especially in women and in older adults. Hemoglobin variants are present in a meaningful percentage of people of African, Mediterranean, South Asian, and Middle Eastern descent. A 2019 study in Frontiers in Endocrinology found that in a population of African adults without overt anemia or nutrient deficiency, A1C alone missed about 60% of diabetes cases and 40% of prediabetes cases compared to the oral glucose tolerance test.¹⁰

Most clinicians know about these confounders in principle. In practice, A1C is often interpreted as if it were a clean measurement.

What the bigger picture looks like

Several other measurements complement A1C and answer questions A1C cannot.

Continuous glucose monitoring (CGM)

CGM shows the actual shape of glucose over a day, including the spikes A1C smooths out. The metric of time in range — the percentage of time your glucose stays within target — is increasingly used alongside A1C in research and clinical care, with international consensus published in 2019.¹

Postprandial glucose testing

Checking blood sugar one to two hours after meals captures the spike pattern. It is simple and inexpensive. It is rarely done routinely.

The dawn phenomenon

This describes the natural pre-breakfast rise in blood sugar that can occur in many people with diabetes. A 2012 study in Diabetes Care found it affects more than half of adults with type 2 diabetes across all age groups, and can elevate A1C by as much as 0.4% on its own.¹¹

Specific nutrient testing

RBC magnesium, methylmalonic acid for functional B12 status, and ferritin for iron can identify deficiencies that serum tests miss or that A1C ignores entirely.

A note on what “in range” means

The American Diabetes Association recommends an A1C target below 7% for many adults with type 2 diabetes. A 2018 guidance statement from the American College of Physicians, after reviewing the major trials, recommended a target range of 7% to 8% for most patients — noting that targets below 7% did not appear to reduce death or major cardiovascular events but did increase the risk of low blood sugar and other harms.¹² Both bodies recommend that targets be individualized based on age, comorbidities, and other factors.

The point is not that one number is right. The point is that “in range” is itself a moving definition, and reasonable specialists disagree on it.

The forms of damage that produce many diabetic symptoms often track better with what A1C misses than with what A1C captures.

What to do with this information

This article is education, not advice. With that said, two things are worth saying.

First, talk to your doctor. Bring up the gap between your A1C and how you actually feel. Ask whether postprandial glucose has ever been measured in your case. Ask what your most recent magnesium and B12 levels were and whether they were measured at all. Ask whether anything in your history — anemia, kidney function, family heritage — could be affecting how your A1C should be interpreted. Do not stop or change any prescribed medication on your own. The conditions those medications are treating are real.

Second, recognize that “your A1C is fine, you’re managing it well” is one piece of a longer answer. The number is real and useful. It is also incomplete by design. If your body has been telling you something is off and the lab keeps coming back normal, the most likely explanation is not that you are imagining it. It is that the standard test was not built to find what you are describing.

The honest summary

A1C is a useful average of blood glucose over the past two to three months. It is also unable to measure glucose variability, post-meal spikes, intracellular nutrient status, or — under various common conditions — its own accuracy. These are not minor caveats. The forms of damage that produce many of the symptoms diabetics report often track better with what A1C misses than with what A1C captures.

What this means in practice is simple. A useful conversation with a doctor treats A1C as one input, not the answer. A useful patient knows what their number is and what their number does not say.

The research is the research. What to do with it is a clinical question.